We are live on ! Find out more
CTXRW

Citius Pharmaceuticals, Inc. Warrant
CTXRW

Delisted

CTXRW was delisted on the 8th of August, 2022.

Back to rankings

1 hedge funds and large institutions have $2K invested in Citius Pharmaceuticals, Inc. Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

86% less capital invested

Capital invested by funds: $14K → $2K (-$12K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$760

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$2K +$760 +1,100 +35%
VF
2
Virtu Financial
New York
– -$12K -23,900 Closed

CTXRW Hedge Fund Activity: Q4 2017 in Review

1 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Citius Pharmaceuticals, Inc. Warrant (CTXRW) for Q4 2017, worth a combined $2K — down 86% from $14K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CTXRW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $760. The largest seller was Virtu Financial, exiting entirely with an estimated $12K sold.

  • 1 institutional investor held Citius Pharmaceuticals, Inc. Warrant (CTXRW) as of Q4 2017, down from 2 in Q3 2017.
  • Funds reported $2K of Citius Pharmaceuticals, Inc. Warrant stock for Q4 2017, down 86% quarter-over-quarter.
  • 0 funds opened new Citius Pharmaceuticals, Inc. Warrant positions in Q4 2017 and 1 closed out, a net change of -1 holder.
  • The largest Citius Pharmaceuticals, Inc. Warrant buyer in Q4 2017 was UBS Group, an estimated $760 added.
  • The largest Citius Pharmaceuticals, Inc. Warrant seller in Q4 2017 was Virtu Financial, an estimated $12K sold.

Based on aggregated 13F filings for Q4 2017.